CHRISTINE OCAMPO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHRISTINE OCAMPO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHRISTINE OCAMPO. CHRISTINE OCAMPO is Vice President, Finance in AVANIR PHARMACEUTICALS, INC. ($AVNR).
Latest Insider Trading Transactions of CHRISTINE OCAMPO
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 18 2011 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | W | 0.00 | 1,350 | 0 | 40,922 | 39.6 K to 40.9 K (+3.41 %) |
Dec 08 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 3.79 | 13,660 | 51,771 | 39,572 | 53.2 K to 39.6 K (-25.66 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 9,000 | 7,920 | 39,000 | |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 1.74 | 14,350 | 24,969 | 115,050 | |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 1.74 | 24,000 | 41,760 | 129,400 | |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | A | 4.18 | 72,500 | 303,050 | 72,500 | |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 4.03 | 9,000 | 36,270 | 53,232 | 62.2 K to 53.2 K (-14.46 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 9,000 | 7,920 | 62,232 | 53.2 K to 62.2 K (+16.91 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 4.03 | 14,350 | 57,831 | 53,232 | 67.6 K to 53.2 K (-21.23 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 1.74 | 14,350 | 24,969 | 67,582 | 53.2 K to 67.6 K (+26.96 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 4.15 | 24,000 | 99,600 | 53,232 | 77.2 K to 53.2 K (-31.08 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 1.74 | 24,000 | 41,760 | 77,232 | 53.2 K to 77.2 K (+45.09 %) |
Dec 03 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Grant | A | 0.00 | 11,250 | 0 | 53,232 | 42 K to 53.2 K (+26.80 %) |
Aug 13 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 0.88 | 12,000 | 10,560 | 36,000 | |
Aug 13 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | M | 1.20 | 16,250 | 19,500 | 3,750 | |
Aug 13 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 3.10 | 12,581 | 39,001 | 41,982 | 54.6 K to 42 K (-23.06 %) |
Aug 13 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 3.11 | 15,669 | 48,731 | 54,563 | 70.2 K to 54.6 K (-22.31 %) |
Aug 13 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 0.88 | 12,000 | 10,560 | 70,232 | 58.2 K to 70.2 K (+20.61 %) |
Aug 13 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | M | 1.20 | 16,250 | 19,500 | 58,232 | 42 K to 58.2 K (+38.71 %) |
Mar 17 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.08 | 200 | 416 | 41,982 | 42.2 K to 42 K (-0.47 %) |
Mar 17 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.08 | 11,000 | 22,886 | 42,182 | 53.2 K to 42.2 K (-20.68 %) |
Mar 17 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.08 | 100 | 208 | 53,182 | 53.3 K to 53.2 K (-0.19 %) |
Mar 17 2010 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Sell | S | 2.08 | 4,218 | 8,773 | 53,282 | 57.5 K to 53.3 K (-7.34 %) |
Nov 30 2009 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | A | 1.74 | 153,400 | 266,916 | 153,400 | |
Feb 25 2009 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | P | 0.44 | 10,900 | 4,796 | 69,400 | 58.5 K to 69.4 K (+18.63 %) |
Feb 25 2009 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Buy | P | 0.42 | 1,000 | 420 | 58,500 | 57.5 K to 58.5 K (+1.74 %) |
Dec 18 2008 | AVNR | AVANIR PHARMACEUTI ... | OCAMPO CHRISTINE | Vice President, Fin ... | Option Exercise | A | 0.53 | 130,000 | 68,900 | 130,000 |
Page: 1